(OTCQB: OTLC) (profile) are responding to this challenge with next-generation delivery platforms engineered to circumvent biological barriers and ensure direct, targeted access to the central nervous ...

Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...

Drawing on insights from the global regulatory landscape, industry trends, and direct feedback from customers, Dr. Di Wu ...

The drug delivery peptide embeds itself in cancer cell membranes and shrinks human tumors in mice more safely than the drug ...

Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), motor neuron disease (MND, including amyotrophic lateral sclerosis, (ALS)), and frontotemporal dementia (FTD) ...

Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.

Drug delivery utilizes various methods and/or carriers to transport therapeutic agents to the tissue, organ, cell, or subcellular organ of interest for release and absorption. Some of the primary ...

Figure 1. A typical polysiloxane structure, where R = CH3, phenyl (aromatic carbon ring), F3CCH2CH2, and CHCH2.(click image to enlarge) Drug-delivery systems are some of the most rapidly proliferating ...

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...

VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...